1. 106520833 逃逸哺乳动物血清清除重组杆状病毒疫苗载体的制备方法
CN
22.03.2017
C12N 15/866 Loading...
C12N 15/866
Loading...
102016001001318
陕西诺威利华生物科技有限公司
张磊
C12N 15/866
Loading...
本发明的制备方法采用克隆PCV2 Cap基因杆状病毒表面展示载体连接，并加上哺乳动物启动子CAGG及报告基因eGFP获得重组转移载体；重组转移载体通过Tn7 转座获得重组杆状病毒Bacmid 载体；重组Bacmid用脂质体方法转染昆虫细胞，收集培养物上清，获得重组杆状病毒，重组杆状病毒感染昆虫细胞，收集细胞做Western blot 分析和共聚焦显微镜分析；并把重组杆状病毒与猪血清作用，发现了与不展示Cap的病毒相比具有很强的逃逸补体清除的能力，从而提高疫苗免疫效力。
2. 106389358 减少过敏反应的注射用头孢哌酮钠舒巴坦钠的药物组合物
CN
15.02.2017
A61K 9/19 Loading...
A61K 9/19
Loading...
102016000984084
重庆福安药业集团庆余堂制药有限公司
蒋晨
A61K 9/19
Loading...
本发明公开了一种减少过敏反应的注射用头孢哌酮钠舒巴坦钠的药物组合物及其制备方法，该药物组合物由头孢哌酮钠和舒巴坦钠组成。此外，本发明还提供了上述注射用头孢哌酮钠舒巴坦钠药物组合物的制备方法。本发明所提供的注射用头孢哌酮钠舒巴坦钠复方药物组合物，其具有溶解速度快、有关物质含量低、产品质量稳定、不良反应小、临床使用安全性好等优势。
3. 104042581 盐酸羟考酮缓控释制剂及其制备方法
CN
19.10.2016
A61K 9/22 Loading...
A61K 9/22
Loading...
102013000082607
中国药科大学
尹莉芳
A61K 9/22
Loading...
本发明涉及一种日服2次的盐酸羟考酮控释制剂及熔融制粒的制备方法。它包括给病人口服固体控释剂量10mg至40mg，在服用后2～4.5小时该制剂给出平均最大血药浓度6至60mg/mL，每12小时重复服用以达稳定状态。该新颖口服制剂具有可变调节释放特性，可实现盐酸羟考酮从速释至延迟释放的特性，获得平稳的血药浓度；减少服用次数，提高患者用药顺应性；减少胃肠道副作用，提高用药安全性。
4. 105924456 一种减少不良反应的头孢米诺钠化合物及其制剂
CN
07.09.2016
C07D 501/57 Loading...
C07D 501/57
Loading...
102016000437149
重庆福安药业集团庆余堂制药有限公司
蒋晨
C07D 501/57
Loading...
本发明涉及一种抗生素药物，具体涉及一种减少不良反应的头孢米诺钠化合物的制备工艺及其制剂，该工艺具有产率高、纯度高等优点，适合工业化生产，所得产品在稳定性、制剂的减少不良反应方面以及临床应用方面都有明显的改善。
5. 105769896 木犀草素-7-二葡萄糖醛酸苷在制备抗心肌损伤或纤维化的药物中的应用
CN
20.07.2016
A61K 31/7048 Loading...
A61K 31/7048
Loading...
102016000114703
上海中医药大学附属岳阳中西医结合医院
张腾
A61K 31/7048
Loading...
本发明涉及木犀草素?7?二葡萄糖醛酸苷在制备抗心肌损伤或纤维化形成药物中的应用。本发明优点在于：采用异丙肾上腺素诱导小鼠心肌损伤的动物模型，对木犀草素?7?二葡萄糖醛酸苷干预心肌损伤的药理作用及分子机制进行了研究，结果表明木犀草素?7?二葡萄糖醛酸苷对异丙肾上腺素诱导的心肌损伤具有显著的抑制作用，主要表现为抑制心肌细胞坏死，肉芽组织形成，炎细胞侵润、纤维化形成等病理表型。运用荧光实时定量PCR，在分子水平揭示并进一步证实了木犀草素?7?二葡萄糖醛酸苷抗心肌纤维化形成的作用，特别是体现在木犀草素?7?二葡萄糖醛酸苷对细胞外基质包括胶原基因表达具有显著的抑制作用。
6. 105685969 一种复方牦牛骨髓口服液及其制备方法
CN
22.06.2016



201610061603.1
中国科学院西北高原生物研究所
杜玉枝


本发明涉及一种复方牦牛骨髓口服液，该口服液由下列重量份的原料制成：牦牛骨粉10~40份，牦牛骨髓5~30份，牦犀胶粉10~40份，牦牛鲜奶40~80份。本发明还公开了该口服液的制备方法。本发明将牦牛鲜骨、牦牛鲜骨髓、牦牛胶粉、牦牛鲜奶进行组合，所得产品具有补钙的功效，同时充分利用了牦牛的原料，提升了青藏高原牦牛资源的价值。
7. 105343107 雷公藤红素在制备防治视网膜退行性改变相关疾病药物中的应用
CN
24.02.2016
A61K 31/56 Loading...
A61K 31/56
Loading...
201510880689.6
上海中医药大学附属岳阳中西医结合医院
陈瑜
A61K 31/56
Loading...
本发明涉及雷公藤红素在制备防治视网膜退行性改变相关疾病药物中的应用。本发明采用视网膜光损伤的小鼠模型，模拟多种视网膜退行性病变发生过程中的共同病理环节，即光感受器细胞死亡，对雷公藤红素抗光感受器细胞死亡、防治视网膜退行性病变发生的作用进行了研究，结果表明雷公藤红素对光损伤诱导的光感受器细胞大量死亡、视网膜结构及功能的损伤具有抑制作用，能治疗并改善视网膜退行性病变，且效果十分显著，因此可用于制备治疗包括年龄相关性黄斑变性、视网膜色素变性、Stargardt病、视锥-视杆细胞营养不良、糖尿病视网膜病变等在内的多种视网膜退行性病变药物，或制备用于相关科学研究的试剂。
8. 104997725 抗HIV病毒的马来酸B07凝胶制剂配方及制备方法
CN
28.10.2015
A61K 9/06 Loading...
A61K 9/06
Loading...
201510404482.1
山西锦波生物医药股份有限公司
姜世勃
A61K 9/06
Loading...
本发明公开了抗HIV病毒的凝胶剂及制备方法。这种抗HIV病毒的温控凝胶剂，以马来酸B07为主要活性成分，以泊洛沙姆为主要的凝胶剂。优化有的温控型凝胶包括以下质量浓度的各组分：马来酸B07？0.2～5%，甘油0.5～5%，透明质酸钠0.015～0.25%，泊洛沙姆407？10～50%，泊洛沙姆188？1～5%，尼泊金甲酯钠0.05～1%，尼泊金丙酯钠0.01～0.8%，苯氧乙醇0.13～0.98%，水为余量。本发明可以用于预防艾滋病传播，具有非常广泛的市场前景和应用价值。
9. 103933058 Application for luteolin-7-diglucuronide in preparation of medicine for treating degenerative retinal diseases
CN
23.07.2014
A61K 31/7048 Loading...
A61K 31/7048
Loading...
201410166181.5
上海中医药大学附属岳阳中西医结合医院
陈瑜
A61K 31/7048
Loading...
The invention relates to an application for luteolin-7-diglucuronide in preparation of a medicine for treating degenerative retinal diseases. According to the application, a mouse model with retinal light injuries is used for simulating a common pathological link during various degenerative retinal disease occurrence processes, namely, photoreceptor cell death, the effects of resisting photoreceptor cell death and preventing the occurrences of degenerative retinal diseases of luteolin-7-diglucuronide are researched, and the result indicates that the compound is capable of maintaining the form of the outer core layer of the retina, preventing the injuries of the outer core layer of the retina, preventing the thickness reduction of the outer core layer of the retina, effectively inhibiting the photoreceptor cell death, and remarkably improving the degenerative retinal diseases, and therefore, luteolin-7-diglucuronide can be used for preparing the medicine for treating degenerative retinal diseases.
10. 103933057 海常素在制备治疗视网膜退行性病变药物中的应用
CN
23.07.2014
A61K 31/7048 Loading...
A61K 31/7048
Loading...
201410166179.8
上海中医药大学附属岳阳中西医结合医院
陈瑜
A61K 31/7048
Loading...
本发明涉及海常素在制备治疗视网膜退行性病变药物中的应用。本发明采用视网膜光损伤的小鼠模型，模拟多种视网膜退行性病变发生过程中的共同病理环节-光感受器细胞死亡，对海常素抗光感受器细胞死亡、防治视网膜退行性病变发生的作用进行了研究，结果表明该化合物能维持视网膜外核层形态、防治视网膜外核层损伤、防治视网膜外核层厚度降低，有效抑制光感受器细胞死亡，显著改善视网膜退行性病变，因此可用于制备治疗视网膜退行性病变的药物。
11. 103820517 调控机体能量代谢的牦牛皮小分子胶原蛋白的制备方法
CN
28.05.2014
C12P 21/06 Loading...
C12P 21/06
Loading...
201410080303.9
中国科学院西北高原生物研究所
杜玉枝
C12P 21/06
Loading...
本发明涉及一种调控机体能量代谢的牦牛皮小分子胶原蛋白的制备方法，该方法包括以下步骤：⑴将新鲜或经浸润、软化后的干燥的青藏高原特有牛种牦牛wild？yak的牦牛皮清洗干净，然后加碱浸泡，得到脱毛后的牦牛皮；⑵脱毛后的牦牛皮加水浸泡脱碱后清水冲洗，得到脱碱脱毛的牦牛皮；⑶脱碱脱毛的牦牛皮剪切成小块，然后加水焯皮，得到脱脂后的牦牛皮；⑷脱脂后的牦牛皮用水进行提取后过滤，弃去残渣，得到滤液；⑸滤液用水稀释后进行分离，即得4Kda小分子的牦牛皮胶原蛋白溶液；⑹将4Kda小分子的牦牛皮胶原蛋白溶液经浓缩、干燥，即得牦牛皮小分子胶原蛋白。本发明方法简单、效果显著，所制得的牦牛皮胶原蛋白分子量分布集中，具有调控机体能量代谢的功能。
12. 103026887 一种大黄藤的扦插繁殖方法
CN
10.04.2013
A01G 1/00 Loading...
A01G 1/00
Loading...
201310002029.9
中国科学院西双版纳热带植物园
刘贵周
A01G 1/00
Loading...
本发明公开了一种大黄藤的扦插繁殖方法。以嫩枝切段为材料，通过对生根剂不同浓度、浸泡时间的筛选，培育小环境的调控，得到一种操作简单、生根快、成活率高，并能在短期内满足生产上大量用苗的种苗繁殖方法。采用本方法可解决生产上种子少、种子繁殖时间长以及种苗缺乏的问题，保证植物药生产企业对原材料的需求。
13. 102977101 多尼培南一水合物、其药物组合物、其制备方法和用途
CN
20.03.2013
C07D 477/20 Loading...
C07D 477/20
Loading...
201110263467.1
中国人民解放军军事医学科学院毒物药物研究所
聂爱华
C07D 477/20
Loading...
本发明属于医药化工领域，涉及一种多尼培南一水合物、其药物组合物、其制备方法和用途。具体地，本发明的多尼培南一水合物的X-射线粉末衍射特征衍射角度(2θ)峰为6.40、10.84、11.20、12.98、14.92、15.22、15.82、16.58、17.42、18.00、19.60、20.60、21.00、22.12、23.06、23.36、23.82、24.42、25.32、26.00、27.90、28.16、28.90、31.62、34.10、和34.84。本发明的多尼培南一水合物具有稳定性好、室温下能够较长时间保存、易溶解于水等优点。
14. 102451178 二氢呋喃-2-酮类化合物在制备抗糖尿病及糖脂代谢药物中的用途
CN
16.05.2012
A61K 31/365 Loading...
A61K 31/365
Loading...
201010525676.4
中国科学院上海药物研究所
冷颖
A61K 31/365
Loading...
本发明属于药物学领域，具体涉及以二氢呋喃-2-酮为母核的具有下述结构式所示的木质素类化合物在制备治疗糖尿病及糖脂代谢药物中的用途，尤其是在II型糖尿病中的用途。
15. 102379873 一种急性全身性猴帕金森病模型及其药物筛选方法
CN
21.03.2012
A61K 31/4418 Loading...
A61K 31/4418
Loading...
201010274015.9
四川大学华西医院
李鹏
A61K 31/4418
Loading...
本发明提供了一种急性全身性猴帕金森病模型的制备方法，将剂量为0.36mg/kg的MPTP施用于猴，每隔一天施用一次，连续施用5次。所述的施用方式是静脉注射。本发明提供了一种筛选治疗急性帕金森病的药物的方法。本发明经外周静脉连续注射MPTP可以建立症状表现类似中晚期帕金森病患者的急性全身性猴帕金森病模型，该模型建模后1-4个月症状较为稳定，其后快速恢复。
16. 102380106 一种猴偏侧帕金森病模型及其药物筛选方法
CN
21.03.2012
A61K 49/00 Loading...
A61K 49/00
Loading...
201010273855.3
四川大学华西医院
李鹏
A61K 49/00
Loading...
本发明提供了一种猴偏侧帕金森病模型的制备方法，将剂量为0.45-0.9mg/kg，施用体积20ml的MPTP，以3ml/min匀速施用于猴。本发明还提供了动物模型在筛选治疗偏侧帕金森病的药物中的用途。本发明还提供了一种筛选治疗偏侧帕金森病的药物的方法。采用本方法建立的偏侧猴帕金森病模型具有症状明显而典型，建模后稳定性较好的优点，实验动物易存活，便于饲养。模型稳定时间较长，可进行多个阶段的药物治疗评价。另外，本模型在整个疾病过程中均可以进行自身对照，节省了模型使用量，符合动物实验伦理学的要求，且更为经济合理。
17. 102370973 一种恒河猴卵巢及卵泡生成模型的制备方法
CN
14.03.2012
A61K 38/24 Loading...
A61K 38/24
Loading...
201010263384.8
四川大学华西医院
王莉
A61K 38/24
Loading...
本发明提供了一种恒河猴卵巢及卵泡生成模型的制备方法，它是由雌性恒河猴为试验对象，经皮下注射促黄体激素LH，60IU/只/次，每天2次，连续7天，制备成恒河猴卵巢及卵泡生成模型。本发明还提供了促黄体激素LH在制备激活卵巢及其卵泡发育的药物中的用途。本发明造模方法使用动物为猴，其生理学、血液学、血液生化等背景数据丰富易得，并且猴与人生物学背景相似，猴的结果能较好地预示药物在临床上反应；多方面、多角度评估，结果能较好、客观地反应药物对生殖系统的药效作用，此外，本模型使用的动物(猴)及仪器(B超仪、显微镜、细胞培养装置等)简单易得，具有通用性。
18. 102334465 大黄素在制备作为急性Stanford A型主动脉夹层预防或伴MODS的脏器保护剂的药物用途
CN
01.02.2012
A01K 67/02 Loading...
A01K 67/02
Loading...
201010608819.8
四川大学华西医院
石应康
A01K 67/02
Loading...
本发明提供了一种急性Stanford A型主动脉夹层伴MODS动物模型的建立方法。本发明还提供了大黄素在制备治疗急性Stanford A型主动脉夹层伴MODS的药物中的用途。本发明还提供了一种急性Stanford A型主动脉夹层伴MODS的脏器保护剂。本发明通过改良AD手术制作方法，同时借助静脉持续泵入肾上腺素形成人工控制性高血压，促进AD剥离范围的扩大和加速病程进展，以快速形成急性Stanford A型AD伴MODS为制作成功模型的目标，本发明急性Stanford A型AD伴MODS的动物模型为进一步深入应用基础研究与干预治疗研究创造条件。
19. 102217980 Preparation method for rhesus monkey choroids angiogenesis models
CN
19.10.2011
A61D 7/00 Loading...
A61D 7/00
Loading...
201010149753.0
Western China Hospital, Sichuan University
Wang Li
A61D 7/00
Loading...
The invention provides a preparation method for rhesus monkey choroids angiogenesis models and also provides an animal model prepared through the method and the application of a VEGF (Vascular Endothecial Growth Factor) inhibitor for preparing medicines with the effect of inhibiting choroids angiogenesis. A rhesus monkey model is established through laser induced choroids angiogenesis, and the VEGF inhibitor is used for rhesus monkey laser induced choroids angiogenesis. The test result shows that the VEGFinhibitor has the effect of inhibiting choroids angiogenesis.
20. WO/2011/116501 ESTABLISHMENT OF RHESUS MONKEY MODEL OF AUTOIMMUNITY TYPE 1 DIABETES
WO
29.09.2011
A61K 49/00 Loading...
A61K 49/00
Loading...
PCT/CN2010/000378
WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
LU, Yanrong
A61K 49/00
Loading...
Use of low dose streptozocin in the preparation of an animal model for screening drugs for treatment of autoimmunity type 1 diabetes is disclosed is disclosed, in which the streptozocin is administrated intravenously in the dose of 15-30 mg/kg per time for 5 days and administered again on the 7th days and 14th days after last time of offering drug. A method for preparing rhesus monkey model of autoimmunity type 1 diabetes and autoimmunity type 1 diabetes animal models obtained are also disclosed.
21. 102198278 Rhesus monkey retinal degeneration model, and drug screening method thereof
CN
28.09.2011
A61K 49/00 Loading...
A61K 49/00
Loading...
201010131148.0
Western China Hospital, Sichuan University
Yan Naihong
A61K 49/00
Loading...
The invention provides a preparation method of a rhesus monkey retinal degeneration model. The method comprises: applying sodium iodate with a dosage of 15 to 75 mg/kg to a rhesus monkey. The invention also provides a method for screening drugs for treating retinal degeneration. According to the invention, for the first time, sodium iodate is applied to the rhesus monkey by intravenous injection for constructing a primate retinal degeneration model, an appropriate molding dosage is selected, and a systemic model assessment system is established.
22. 102166235 Extraction and purification method of saikosaponin
CN
31.08.2011
A61K 36/233 Loading...
A61K 36/233
Loading...
201110103405.4
Sichuan Depeiyuan Traditional Chinese Medicine Technology Development Co., Ltd.
Yu Boyang
A61K 36/233
Loading...
The invention discloses an extraction and purification method of saikosaponin. The saponin part mainly contains saikosaponin a and saikosaponin d. The extract can be prepared by using a percolation method or a high-pressure percolation method, an ethanol solution is used for extracting bupleurum medicinal material, macroporous resin is used for purifying in the purification process, the total weight of the saikosaponin a and saikosaponin d in the prepared saikosaponin extract accounts for 30-60% of the weight of the extract, and the weight of the total saponins accounts for 50-80% of the weight of the extract. The method disclosed by the invention is simple to operate, has the advantages of low production cost, energy saving and high extraction efficiency, and is suitable for industrialized production.
23. 201839690 猴延迟取食实验训练装置
CN
25.05.2011
A01K 15/02 Loading...
A01K 15/02
Loading...
201020523070.2
四川大学华西医院
程峰
A01K 15/02
Loading...
一种猴延迟取食实验训练装置，在装置体上有2-5个凹槽，凹槽上有盖板，盖板通过销轴安装在装置体上，盖板可绕销轴转动。本实用新型结构紧凑，使用方便，将训练和喂食同时进行，猴易于接受，缩短了前期的适应期，并将成功记忆与食物奖励机制自动结合起来，能十分有效地训练、观测猴的记忆力。
24. 201790814 一种猴用磁共振扫描固定器
CN
13.04.2011
A61B 5/055 Loading...
A61B 5/055
Loading...
201020518795.2
四川大学华西医院
邹翎
A61B 5/055
Loading...
一种猴用磁共振扫描固定器，为头套形塑料结构，内径20-25cm，头套内层有气囊，下部有袢扣，背面有自动粘扣带可与扫描仪内部固定带粘贴。本实用新型通过对气囊充气，可对不同大小的猴头予以良好固定，不会对猴头造成伤害，使猴头在扫描时处于理想的静止状态，结构简单、紧凑，使用方便。
25. 101991569 Rhesus monkey temporal lobe epilepsy kindling model and drug screening method thereof
CN
30.03.2011
A61K 49/00 Loading...
A61K 49/00
Loading...
200910164207.1
West China Hospital, Sichuan University
Zhou Dong
A61K 49/00
Loading...
The invention provides a rhesus monkey temporal lobe epilepsy kindling model. In the model, coriamyrtin with the subthreshold seizure dose of 0.5 ml/kg is applied in rhesus monkey, and the effect of 1ml of coriamyrtin injection is equivalent to that of 6.7g of raw material medicine Chinese coriaria leaf. The invention also provides a method for screening drugs for curing temporal lobe epilepsy. The method of the invention has the following advantages: the method is simple to establish and easy to operate and repeat, does not cause mechanical damage on the brain, has short seizure time, etc. The model of the invention resists the classical antiepileptic drug carbamazepine, thus the model can be used in the research on the pathogenesis of the temporal lobe epilepsy and the research on the development of new antiepileptic drugs.
26. 101986834 Method for preparing rhesus focal cerebral ischemia model
CN
23.03.2011
A01K 67/027 Loading...
A01K 67/027
Loading...
200910060244.8
Western China Hospital, Sichuan University
He Li
A01K 67/027
Loading...
The invention provides a method for preparing a rhesus focal cerebral ischemia model, which adopts a spring ring plug for building an animal model. The invention also provides a method for sieving medicines for treating the focal cerebral ischemia, which comprises the following steps of: a. adopting the rhesus focal cerebral ischemia model; b. applying all candidate medicines to the rhesus; and c. observing the condition of the medicine inhibition of the rhesus focal cerebral ischemia model, carrying out mark grading, and evaluating potential medicines for treating the focal cerebral ischemia. The rhesus focal cerebral ischemia model is built by adopting a method of intervening the spring ring plug into the blood vessel, has higher stability, higher safety and better repeatability, and belongs to the rhesus focal cerebral ischemia model, which can perfectly simulate the clinic use, is simple and convenient and can be easily implemented.
27. 201709220 一种行为观察型动物笼具
CN
19.01.2011
A01K 1/03 Loading...
A01K 1/03
Loading...
201020187668.9
四川大学华西医院
王莉
A01K 1/03
Loading...
一种行为观察型动物笼具，所述笼具的上方是顶网，左右两侧有透明钢化玻璃，前方是活动门，活动门上有饮水盒和食料盒，笼底设置有粪尿盘。本实用新型可在不干扰动物的情况下24小时全方位对笼中动物进行观察，尤其适用对猴类进行行为观察，可以观察到最接近其本性的动物行为，还能安全、方便地进行实验操作。
28. 101843528 Long-term administration method by monkey femoral venous catheter
CN
29.09.2010
A61D 7/00 Loading...
A61D 7/00
Loading...
200910058683.5
Chengdu Western Haiqi Pharmaceutical Technology Co., Ltd.
Cheng Feng
A61D 7/00
Loading...
The invention provides a long-term administration method by a monkey femoral venous catheter. The method comprises the following steps: a, preoperative preparation: in a preoperative week, a vest is worn for a crab-eating macaque to conduct adaptive training, and preoperative fasting is conducted for 12 hours; b, operation: after conducting anesthesia, the venous catheter is implanted into the inguinal part; c, postoperative maintenance; d, detection of a physiological value; and e, administration: an infusion pump is fixed on the vest, an infusion tube of the infusion pump is butted with the tail end of a channel of the catheter, and the infusing and injecting speed and time are set to conduct the infusion. The administration method has the advantages of: firstly, being capable of administrating continuously within several hours; secondly, administrating at a constant speed, thus guaranteeing blood concentration to be continuously stabilized above the lowest effective concentration; thirdly, being capable of administrating under the condition that an animal is sober, having no influence on the self movement of the animal, and being more humanistic; and in addition, also being easy to operate for an experimenter.
29. 101843906 Rhesus monkey seizure model and drug screening method thereof
CN
29.09.2010
A61K 49/00 Loading...
A61K 49/00
Loading...
200910058682.0
Chengdu Western Haiqi Pharmaceutical Technology Co., Ltd.
Gu Rui
A61K 49/00
Loading...
The invention provides a method for preparing a rhesus monkey seizure model. The method comprises applying 0.5-0.7ml/kg of coriamyrtin to the rhesus monkey to induce the seizure. The invention also provides the application of the animal model in screening the drugs for treating the seizure. Compared with the other temporal epilepsy models, the research has the following advantages: (1) the drugs are systematically delivered by means of intramuscular injection, which is convenient to operate; (2) the seizure induction dosage is poorly correlated in the gender or age of the animal; (3) the repetition is good; (4) the electrode is convenient to install; (5) no direct mechanical damage is caused in the drain; (6) the seizure induction process is clear; and (7) the drug safety is good.
30. 101812041 Three cassane type diterpenoid lactone compounds with activity against plasmodium falciparum
CN
25.08.2010
C07D 307/77 Loading...
C07D 307/77
Loading...
200910009373.4
Guangxi Botanical Garden of Medicinal Plant
Cheng Yan
C07D 307/77
Loading...
The invention relates to a type of cassane type diterpenoid lactone compounds with activity against plasmodium falciparum, which are prepared by taking seeds of a leguminous medicinal plant of caesalpinia minax hance as raw materials, using a specific solvent for extraction, carrying out a variety of chromatography and finally obtaining three cassane type diterpenoid lactone monomeric compounds, which are 5 alpha, 14 beta-dihydroxy-1 alpha, 6 alpha, 7 beta-triacetyl-13(15), 11(12)-diene-16, 12-lactone (I), 12 alpha-methoxy, 5 alpha, 14 beta-dihydroxy-1 alpha, 6 alpha, 7 beta-triacetyl-13(15)-ene-16, 12-lactone (II) and neocaesalpin L (III) respectively, wherein the compound I and the compound II are new compounds. The first research test of in vitro anti-malarial pharmacodynamics of the three compounds shows that the three compounds have obvious effect of suppressing the plasmodium falciparum and can be used for preparing drugs for treating and/or preventing malaria.
31. 101628051 Preparation method of Houttuynia cordata injection
CN
20.01.2010
A61K 36/78 Loading...
A61K 36/78
Loading...
200910090863.1
Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Li Lianda
A61K 36/78
Loading...
The invention discloses a Houttuynia cordata injection and a preparation method thereof, and the Houttuynia cordata injection is prepared by the following method: taking fresh Houttuynia cordata, carrying out water vapor distillation, collecting initial distillate, carrying out re-distillation, collecting re-distillate, adding 4-25g of hydroxypropyl-beta-cyclodextrin and 7-9g of sodium chloride into each 1000ml of re-distillate, and preparing the injection according to the conventional method. The preparation method takes the Houttuynia cordata injection as a research object, seeks harmful components/allergic sources which can cause adverse reactions, investigates the allergic mechanism, improves the production process and successfully develops the new safe Houttuynia cordata injection.
32. 101474282 Chinese medicinal compound for treating bronchial asthma and preparation method thereof
CN
08.07.2009
A61K 36/758 Loading...
A61K 36/758
Loading...
200910020988.7
Fourth Military Medical University
Wang Shengchun
A61K 36/758
Loading...
The invention relates to a Chinese herbal medicine compound, in particular to a Chinese herbal medicine compound with the effect of curing bronchial asthma. The compound is characterized in that the compound is extracted from mature pricklyash seed of rutaceae plant zanthoxylum dimorphophyllum. The Chinese herbal medicine compound can play a role in preparing bronchial asthma medicines and has excellent therapeutic effect and high safety.
33. 101396428 Tibetan capillary extract and preparation method, medicine composition and use thereof
CN
01.04.2009
A61K 36/51 Loading...
A61K 36/51
Loading...
200710163097.8
Northwest institute of plateau biology, Chinese academy of sciences
Wei Lixin
A61K 36/51
Loading...
The invention provides a Tibetan virgate wormwood herb extract containing swertiamain, gentiopicroside, sweroside, mangiferin and isoorientin, and the weight ratio of the five ingredients is (0.04-0.71): (20-40): (1-15): (1.6-26): (0.01-0.16). The invention further provides a preparation method of the Tibetan virgate wormwood herb extract, a pharmaceutical composition containing the Tibetan virgate wormwood herb extract and a medical use of the Tibetan virgate wormwood herb extract. The Tibetan virgate wormwood herb extract can improve various indicators caused by liver injury, promote the reversal of the liver fibrosis process and better prevent liver cirrhosis.
34. 101252953 Electrotransfer of nucleic acid into tissue cells
CN
27.08.2008
A61K 48/00 Loading...
A61K 48/00
Loading...
200680031640.2
Bioalliance Pharma
Mir Luis
A61K 48/00
Loading...
The electrotransfer of a nucleic acid into tissue cells, in particular in a muscle or a tumoral tissue, is carried out by an electric stimulation of the tissue as follows: - first with at least one, preferably a single, pulse of a High Voltage field strength of between 200 and 2000 volts/cm - second with a single pulse of Low Voltage field strength of between 50 and 200 volts/cm an d of duration of between 300 ms and 2000 ms.
35. 101214269 Method for extracting and concentrating total flavones of ilex hainanensis
CN
09.07.2008
A61K 36/185 Loading...
A61K 36/185
Loading...
200710303509.3
Guangxi Zhuang Autonomous Region Institute of Traditional Chinese Medicine
Lai Maoxiang
A61K 36/185
Loading...
A method of extracting Hainan holly-enriched total flavone is characterized by extracting steps that the raw material of the Hainan holly is processed for reflux extraction by the ethanol with the weight concentration of 40 percent to 95 percent; the concentrated extract is put into a HPD-400 macroporous resin column to be processed for gradient elution by the ethanol containing water; an ethanol eluted part with the concentration of 20 percent to 50 percent is collected; the total flavone is obtained after the solvent is returned and the part is dried. The method of extracting the Hainan holly-enriched total flavone of the present invention enriches active components selectively during the extracting process and removes a plurality of immunities; the content of the total flavone in an obtained product is more than 50 percent; at the same time, the method has good repeatability and stability, so as to ensure the stability of the curative effective; the effective component of raw material has high transfer rate and low cost; the method is simple and convenient for operating and is fit for the industrialization production.
36. 101185414 Artificial fecundation method for flemingia macrophylla
CN
28.05.2008
A01G 31/00 Loading...
A01G 31/00
Loading...
200710066488.8
Xishuangbanna Tropical Botanical Garden
Dao Xiangsheng
A01G 31/00
Loading...
The invention discloses an artificial propagation method of big leaves moghania, comprising the steps of harvesting seeds, seedbed establishment, seed treatment, planting and pregermination, seedbed management, bagging, bed out and nursery management, etc. The invention utilizes the big leaves moghania seeds to culture nursery stock, and firstly realizes the artificial propagation of the big leaves moghania, thus providing sufficient materials for production of enterprises and realizing scientific utilization of plant resources; while helping farmers shake off poverty and set out on a road to prosperity, environment is protected, water loss and soil erosion is prevented, and the invention is provided with a good market application prospect.
37. 100999550 Tubercle branch bacillus fusion protein and application thereof
CN
18.07.2007
C07K 19/00 Loading...
C07K 19/00
Loading...
200610000710.X
No.2 Hospital Attached to General Hospital, PLA
He Xiuyun
C07K 19/00
Loading...
The present invention relates to one kind of mycobacterium tuberculosis fusion protein, polynucleotides coding the polypeptide, the vector including the polynucleotides and the host cell. The present invention also relates to the preparation of the fusion protein and the application of the fusion protein in preventing and treating tuberculosis.
38. WO/2007/056955 PYRAZOLOPYRIMIDINONE DERIVATIVES, THEIR PREPARATION AND THEIR USE
WO
24.05.2007
C07D 487/04 Loading...
C07D 487/04
Loading...
PCT/CN2006/003094
TOPHARMAN SHANGHAI CO., LTD.
TIAN, Guanghui
C07D 487/04
Loading...
Pyrazolopyrimidinone derivatives, which have the following formula, their preparation and their use.Such derivatives show potent activity against PDE5 proved by pharmacological test, and parts of them show distinctly more powerful inhibiting activity against PDE5 than against PDE6. A majority of the compounds has low toxicity. Such derivatives are useful clinically in improving or treating the disorders or diseases of cardiovascular system or urinary system, and especially in improving or treating the disorders or diseases including erection dysfunction.
39. WO/2007/012276 A MEDICINE FOR ABSTAINING FROM ADDICTION TO DRUGS AND PROCESS THEREOF
WO
01.02.2007
A61K 36/8968 Loading...
A61K 36/8968
Loading...
PCT/CN2006/001856
SHANXI YABAO PHARMACEUTICAL GROUP CORP.
YANG, Zheng
A61K 36/8968
Loading...
An extract for abstaining from addiction to drugs, its composition, as well as process and quality control method thereof. The extract is extracted from stephania delavayi diels. The raw materials of the composition are radix ginseng, stephania delavayi diels, radix astragali, radix angelicae sinensis and radix ophiopogonis. The composition also can be prepared by using ethanol extract of radix ginseng, ethanol extract of radix angelicae sinensis, alkaloid of stephania delavayi diels, water extract of radix astragali and water extract of ophiopogonis. The quality control method of the composition include one or more of identification and content measurement. The use of the extract, the composition in the manufacture of a medicine for abstaining from addiction to drugs.
40. 1821332 Method for producing linen glue
CN
23.08.2006
C09F 1/00 Loading...
C09F 1/00
Loading...
200610012361.3
Shanxi Inst. of Coal Chemistry, CAS
Hou Xianglin
C09F 1/00
Loading...
The production process of linen glue with linen seed as material includes the following steps: mixing linen seed with 1.0-10.0 % concentration alkali solution, 85-100 % concentration water solution or 0.1-5.0 % concentration alcohol water solution of alkali at 20-50 deg.c to extract lignin compltetely, filtering, scalding the filter cake with 95-100 deg.c water for 5-15 min, mixing the filter cake with water at 25-55 deg.c, xylanase and mycoprotein polysaccharide enzyme through stirring, filtering, re-extracting the filter cake, merging filtrate, and drying to obtain linen glue. The present invention has high linen glue extracting efficiency, and the linen glue product has linen glue polysaccharide content over 90 wt%, low protein content and no pollutant.
41. 1657059 Shenkeshu capsule for treating chronic renal failure and its preparation technology
CN
24.08.2005
A61K 36/708 Loading...
A61K 36/708
Loading...
200410004358.8
Jiangxi Jinshuibao Pharmaceutical Co., Ltd.
Xiong Yulan
A61K 36/708
Loading...
A medicine in the form of capsule for treating chronic renal failure is prepared from the fermented cordyceps powder through reflux extracting in alcohol, filtering, vacuum recovering of alcohol, concentrating, vacuum drying, pulverizing, mixing it with beta-dextrin and magnesium stearate, granulating and loading in capsules.
42. 1654062 Freeze dried powder injection for treating thromboangitis obliterans and its preparing process
CN
17.08.2005
A61K 9/19 Loading...
A61K 9/19
Loading...
200410039431.5
Shanxi Yabao Pharmaceutical Group Co., Ltd.
Li Yaping
A61K 9/19
Loading...
The present invention discloses one kind of freeze dried Mailuoning powder for injection and its preparation process. The freeze dried Mailuoning powder for injection is prepared with the medicinal parts of plant materials honeysuckle, figwort, achyranthes root and dendrobium stem and excipient, and through dilute ethanol solution reflux extraction of honeysuckle, ethanol solution reflux extraction, water decoction and alcohol precipitation of figwort, water decoction and alcohol precipitation of achyranthes root and water decoction and alcohol precipitation of dendrobium stem. Compared with available other Mailuoning preparation forms, the present invention has scientific and reasonable extraction process, higher stability, higher quality, lower toxicity, and convenient storage, transportation and use.
43. 1640421 Injection danhong of radix salviae miltorrhizae and flos carthami, and its preparing method and quality control method
CN
20.07.2005
A61K 36/53 Loading...
A61K 36/53
Loading...
200410000321.8
Yabao Pharmaceutical Group Co., Ltd., Shanxi
Li Yaping
A61K 36/53
Loading...
The present invention discloses a Chinese medicine Danhong injection made up by using Chinese medicinal materials of salvia root and carthamus flower as raw material, its preparation process and content determination method. Said preparation process includes the following steps: making salvia root undergo the process of ethanolic reflux extraction, using water to decoct the salvia root which is undergone the process of ethanolic reflux extraction, combining decoctions and filtering to obtain salvia root extract; making carthamus flower undergo the process of ethanolic impregnating extraction and filtering to obtain carthamus flower extract; then uniformly mixing the above-mentioned two extracts so as to obtain the invented injection.
44. 1634208 Injetio for treating coronary heart disease and its preparation process
CN
06.07.2005
A61K 36/53 Loading...
A61K 36/53
Loading...
200310122469.4
Shanxi Yabao Pharmaceutical Group Co., Ltd.
Li Yaping
A61K 36/53
Loading...
The invention provides a method for preparing freeze dried injection for stable angina pectoris of coronary heart disease, which comprises the significant part of radix salvia miltiorrhiza, Ligusticum wallichii and excipient, wherein the preparing process comprises stirring, dissolving, filtrating, charging water for injection and adjusting pH, an extraction method integrating ethanol backflow and water grilling is employed to extract the significant part of the root of red-rooted salvia, and the method integrating ultrasonic abstraction and water grilling is employed to extract the significant part of the root of chuanxiong rhizome. The invention also discloses the method of quality control for the freeze dried injection.
45. 1628738 'Shengmai' injection and its preparation process
CN
22.06.2005
A61K 9/19 Loading...
A61K 9/19
Loading...
200310121126.6
Shanxi Yabao Pharmaceutical Group Co., Ltd.
Li Yaping
A61K 9/19
Loading...
The freeze-drying powder injection provided by the invention is prepared from medicinal herbs including red ginseng, tuber of dwarf lilyturf and schisandra chinensis as the medicinal components as well as excipient. Compared with the prior art liquid injection preparation, the invention has the advantages of higher quality standard, more comprehensive medicinal components extraction, better effects, lower toxicity, and convenience in transport, storage and use.
46. 1596574 Variety introduction cultivating method of rheum officinale plant
CN
23.03.2005
A01C 1/00 Loading...
A01C 1/00
Loading...
03134622.7
Plateau Biology Inst., Chinese Academy of Sciences Northwest
Chen Guishen
A01C 1/00
Loading...
A method for cultivating the plant rhubarb includes such steps as physically and chemically treating seeds for high germination rate, artificial breeding, and cultivating.
47. 1484529 Gusuibu extracts for trvating osteoporosis and method for extracting same
CN
24.03.2004
A61K 31/35 Loading...
A61K 31/35
Loading...
00820138.2
Qihuang Pharmaceutical Science and Technology Investment Co., Ltd.
Xie Yanming
A61K 31/35
Loading...
An extraction of drynaria, characterised in that the content of total flavone is more than 30%, and the content of naringin is more than 30%, but less than 100%. Said extraction can be used for treating osteoporosis or preparing medicaments for treating osteoporosis. The extraction process of said extraction.
48. 2239241 一次性美容手术敷料包
CN
06.11.1996
A61B 19/02 Loading...
A61B 19/02
Loading...
95245242.1
中国人民解放军第四军医大学第一附属医院医教部
阎则玲
A61B 19/02
Loading...
一次性美容手术敷料包，具有15号手术刀、注射器、麻醉注射液、小三角缝针、线、手套、棉球与敷料等一次性美容手术用品，其特征为将这些手术器械与敷料结构合理、紧凑地放入一塑料方盒中，用双层塑料袋密封、消毒，本实用新型轻便，价格低廉、消毒可靠、使用方便、卫生，解决了非一次性使用所带来的肝炎等病毒传播的可能，实为美容手术的理想用品。

